Cervical intraepithelial neoplasia (CIN) in pregnancy: The state of the art

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 6, 2014, Pages 851-860

  Origoni, M ^a   Salvatore, S ^a   Perino, A ^b   Cucinella, G ^b   Candiani, M ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cervical Intraepithelial Neoplasia; CIN; Guidelines; Pregnancy; Screening

Indexed keywords

ADENOCARCINOMA; ARTICLE; ATYPICAL GLANDULAR CELL; CELL TYPE; COLD KNIFE CONIZATION; COLPOSCOPY; COMPLICATION; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; LARGE LOOP EXCISION OF THE TRANSFORMATION ZONE; PAPANICOLAOU TEST; PREGNANT WOMAN; PREVALENCE; RISK FACTOR; SURGICAL TECHNIQUE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; PATHOLOGY; PREGNANCY; UTERINE CERVICAL NEOPLASMS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; PREGNANCY; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84902106637     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. HAAS JF. Pregnancy in association with a newly diagnosed cancer: a population-based epidemiologic assessment. Int J Cancer 1984; 34: 229-235.
2. LUTZ MH, UNDERWOOD PB JR, ROZIER JC, PUTNEY FW. Genital malignancy in pregnancy. Am J Obstet Gynecol 1977; 129: 536-542.
3. SMITH LH, DANIELSEN B, ALLEN ME, CRESS R. Cancer associated with obstetric delivery: Results of linkage with the California cancer registry. Am J Obstet Gynecol 2003; 189: 1128-1135.
4. MORIMURA Y, FUJIMORI K, SOEDA S, HASHIMOTO T, TAKANO Y, YAMADA H, YANAGIDA K, SATO A. Cervical cytology during pregnancy - comparison with nonpregnant women and management of pregnant women with abnormal cytology. Fukushima J Med Sci 2002; 48: 27-37.
5. MCINTYRE-SELTMAN K, LESNOCK JL. Cervical cancer screening in pregnancy.Obstet Gynecol Clin North Am 2008; 35: 645-658.
6. INSINGA RP, GLASS AG, RUSH BB. Diagnoses and outcomes in cervical cancer screening: a populationbased study. Am J Obstet Gynecol 2004; 191: 105-113.
7. HUNTER MI, MONK BJ, TEWARI KS. Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. Am J Obstet Gynecol 2008; 199: 3-9.
8. AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS. ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas. Int J Gynaecol Obstet 2002; 78: 79-91.
9. AL-HALAL H, KEZOUH A, ABENHAIM HA. Incidence and obstetrical outcomes of cervical intraepithelial1120. neoplasia and cervical cancer in pregnancy: A population-based study on 8.8 million births. Arch Gynecol Obstet 2013; 287: 245-250.
10. HACKER NF, BEREK JS, LAGASSE LD, CHARLES EH, SAVAGE EW, MOORE JG. Carcinoma of the cervix associated with pregnancy. Obstet Gynecol 1982; 59: 735-746.
11. CUSCHIERI KS, CUBIE HA, WHITLEY MW, GILKISON G, ARENDS MJ, GRAHAM C, MCGOOGAN E. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol 2005; 58: 946-950.
12. DALRYMPLE JL, GILBERT WM, LEISEROWITZ GS, CRESS R, XING G, DANIELSEN B, SMITH LH. Pregnancy-associated cervical cancer: obstetric outcomes. J Mat Fetal Neonatal Med 2005; 17: 269-276.
13. SCREENING FOR CERVICAL CANCER. Topic page. January 2003. U.S. Preventive service task force. Agency for Healthcare Research and Quality. Rockville, MD. Available at: http://www.ahrq.gov/clinic/uspstf/uspscerv.htm.
14. UBERTI-FOPPA C, ORIGONI M, MAILLARD M, FERRARI D, CIUFFREDA D, MASTRORILLI E, LAZZARIN A, LILLO F. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women. J Med Virol 1998; 56: 133-137.
15. ORIGONI M, STEFANI C, GELARDI C, CARMINATI G, SALVATORE S, CANDIANI M. Worsening immunodeficiency correlates with increasing frequency of HPV-correlated cervical intraepithelial lesions in HIV-infected women. It J Gynaecol Obstet 2012; 24: 174-180.
16. SERESINI S, ORIGONI M, CAPUTO L, LILLO F, LONGHI R, VANTINI S, PAGANONI AM, PROTTI MP. CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix. Immunology 2010; 131: 89-98.
17. SERESINI S, ORIGONI M, LILLO F, CAPUTO L, PAGANONI AM, VANTINI S, PROTTI MP. IFN-γ produced by human papilloma virus-18 E6-specific CD4 + T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesions. J Immunol 2007; 17910: 7176-7183.
18. ORIGONI M, STEFANI C, DELL'ANTONIO G, CARMINATI G, PARMA M, CANDIANI M. Cervical Human papillomavirus in transplanted Italian women: A longterm prospective follow-up study. J Clin Virol 2011; 51: 246-250.
19. FIFE KH, KATZ BP, ROUSH J. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol 1996; 174: 1487-1452.
20. JENSEN KE, SCHMIEDEL S, NORRILD B, FREDERIKSEN K, IFTNER T, KJAER SK. Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up. Br J Cancer 2013; 108: 234-239.
21. CUBO-ABERT M, CENTENO-MEDIAVILLA C, FRANCO-ZABALA P. Risk factors for progression or persistence of squamous intraepithelial lesions diagnosed during pregnancy. J Low Gen Tract Dis 2012; 16: 34-38.
22. ECONOMOS K, PEREZ VERIDIANO N, DELKE I, COLLADO ML, TANCER ML. Abnormal cervical cytology in pregnancy: a 17-year experience. Obstet Gynecol 1993; 81: 915-918.
23. BENEDET JL, SELKE PA, NICKERSON KG. Colposcopic evaluation of abnormal Papanicolaou smears in regnancy. Am J Obstet Gynecol 1987; 157: 932-937.
24. STILLSON T, KNIGHT AL, ELSWICK JR RK. The effectiveness and safety of two cervical cytologic techniques during pregnancy. J Fam Pract 1997; 45: 159-163.
25. CONNOLLY TP, EVANS AC. Atypical Papanicolaou smear in pregnancy. Clin Med Res 2005; 3: 13-18.
26. COLEMAN CA. Evaluation and management of abnormal cervical cytology during pregnancy. Clin Obstet Gynecol 2013; 56: 51-54.
27. SHERMAN ME, SCHIFFMAN M, HERRERO R, KELLY D, BRATTI C, MANGO LJ, ALFARO M. HUTCHINSON ML, MENA F, HILDESHEIM A, MORALES J, GREENBERG MD, BALMACEDA I, LORINCS AT. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica Cancer 1998; 84: 273-280.
28. JAIN AG, HIGGINS RV, BOYLE MJ. Management of lowgrade squamous intraepithelial lesions during pregnancy. Am J Obstet Gynecol 1997; 177: 298-302.
29. MICHAEL CW, ESFAHANI FM. Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol 1997; 17: 99-107.
30. BALDAUF JJ, DREYFUS M, GAO J, RITTER J, PHILIPPE E. Management of pregnant women with abnormal cervical smears. A series of 146 patients. J Gynecol Obstet Biol Reprod 1996; 25: 582-587.
31. WRIGHT JR TC, MASSAD LS, DUNTON CJ, SPITZER M, WILKINSON EJ, SOLOMON D. 2006 ASCCP-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. Am J Obstet Gynecol 2007; 197: 346-355.
32. LIEBERMAN RW, HENRY MR, LASKIN WB, WALENGA J, BUCKNER SB, O'CONNOR DM. Colposcopy in pregnancy: directed brush cytology compared with cervical biopsy. Obstet Gynecol 1999; 94: 198-203.
33. YOST NP, SANTOSO JT, MCINTIRE DD, ILIYA FA. Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions.Obstet Gynecol 1999; 93: 359-362.
34. PARASKEVAIDIS E, KOLIOPOULOS G, KALANTARIDOU S, PAPPA L, NAVROZOGLOU I, K. ZIKOPOULOS, LOLIS DE. Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum.Eur J Obstet Gynecol Reprod Biol 2002; 104: 67-69.
35. AHDOOT D, VAN NOSTRAND KM, NGUYEN NJ, TEWARI DS, KURASAKI T, DISAIA PJ, ROSE GS. The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum period. Am J Obstet Gynecol 1998; 178: 1116-1120.
36. COPPOLILLO EF, DE RUDA VEGA HM, BRIZUELA J, ELISETH MC, BARATA A, PERAZZI BE. High-grade cervical neoplasia during pregnancy: diagnosis, management and postpartum findings. Acta Obstet Gynecol Scand 2013; 92: 293-297.
37. KAPLAN KJ, DAINTY LA, DOLINSKY B, ROSE GS, CARLSON J, MCHALE M, ELKAS JC. Prognosis and recurrence risk for patients with cervical squamous intraepithelial lesions diagnosed during pregnancy. Cancer 2004; 102: 228-232.
38. BRINTON LA, REEVES WC, BRENES MM, HERRERO R, DE BRITTON RC, GAITAN E, TENORIO F, GARCIA M, RAWLS WE. Parity as a risk factor for cervical cancer. Am J Epidemiol 1989; 130: 486-496.
39. KANESHIRO BE, ACOBA JD, HOLZMAN J, WACHI K, CARNEY ME. Effect of delivery route on natural history of cervical dysplasia. Am J Obstet Gynecol 2005; 192: 1452-1454.
40. FREGA A, SCIRPA P, COROSU R, VERRICO M, SCARCIGLIA ML, PRIMIERI MR, PALAZZO A, IACOVELLI R, MOSCARINI M. Clinical management and follow-up of squamous intraepithelial cervical lesions during pregnancy and postpartum. Anticancer Res 2007; 27: 2743-2746.
41. MASSAD LS, EINSTEIN MH, HUH WK, KATKI HA, KINNEY WK, SCHIFFMAN M, SOLOMON D, WENTZENSEN N, LAWSON HW. 2012 Updated Consensus Guidelines for the Management Of Abnormal Cervical Cancer Screening Tests And Cancers Precursors. J Low Gen Tract Dis 2013; 17: S1-S27.
42. ASCUS-LSIL TRIAGE STUDY (ALTS) GROUP. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188: 1383-1392.
43. ORIGONI M, CRISTOFORONI P, COSTA S, MARIANI L, SCIRPA P, LORINCZ A, SIDERI M. HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice. Ecancermedicalscience. 2012; 6: 258. doi: 10.3332/ecancer.2012.258.
44. CLAVEL C, MASURE M, BORY JP, PUTAUD I, MANGEONJEAN C, LORENZATO M, NAZEYROLLAS P, GABRIEL R, QUEREUX C, BIREMBAUT P. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001; 84: 1616-1623.
45. FADER AN, ALWARD EK, NIEDERHAUSER A, CHIRICO C, LESNOCK JL, ZWIESLER DJ, GUIDO RS, LOFGREN DJ, GOLD MA, MOORE KN. Cervical dysplasia in pregnancy: a multi-institutional evaluation. Am J Obstet Gynecol 2010; 203: 113.e1-6.
46. DUNN TS, BAJAJ JE, STAMM CA, BEATY B. Management of the minimally abnormal papanicolaou smear in pregnancy. J Low Genit Tract Dis 2001; 5: 133-137.
47. M. ORIGONI, G. CARMINATI, S. ROLLA, M. CLEMENTI, M. SIDERI, M.T. SANDRI, M. CANDIANI. Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology. Eur J Clin Microbiol Infect Dis 2012; 31: 2401-2406.
48. ORIGONI M, CARMINATI G, SIDERI M, CLEMENTI M, ROLLA S, CANDIANI M. "Low-grade positivity" of HPV viral load after atypical squamous cells of undetermined significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3. Eur J Gynaecol Oncol. 2012; 33: 261-264.
49. WRIGHT JR TC, MASSAD LS, DUNTON CJ, SPITZER M, WILKINSON EJ, SOLOMON D. 2006 American Society for Colposcopy and Cervical Pathologysponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007; 197: 340-345.
50. KE. SHARPLESS, PF. SCHNATZ, S. MANDAVILLI, JF. GREENE, JI. SOROSKY. Dysplasia associated with atypical glandular cells on cervical cytology. Obstet Gynecol 2005; 105: 494-500.
51. DE SIMONE CP, DAY ME, TOVAR MM, DIETRICH 3RD CS, EASTHAM ML, MODESITT SC. Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature. Obstet Gynecol 2006; 107: 1285-1291.
52. TAM KF, CHEUNG AN, LIU KL, NG TY, PUN TC, CHAN YM, WONG LC, NGAN HY. A retrospective review on atypical glandular cells of undetermined significance (AGUS) using the Bethesda 2001 classification. Gynecol Oncol 2003; 91: 603-607.
53. DERCHAIN SF, RABELO-SANTOS SH, SARIAN LO, ZEFERINO LC. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol 2004; 95: 618-623.
54. DIAZ-MONTES TP, FARINOLA MA, ZAHURAK ML, BRISTOW RE, ROSENTHAL DL. Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results. Gynecol Oncol 2007; 104: 366-371.
55. FOUNTA C, ARBYN M, VALASOULIS G, KYRGIOU M, TSILI A, MARTIN-HIRSCH P, DALKALITSIS N, KARAKITSOS P, KASSANOS D, PRENDIVILLE W, LOUFOPOULOS A, PARASKEVAIDIS E. Proportion of excision and cervical healing after large loop excision of the transformation zone for cervical intraepithelial neoplasia. BJOG 2010; 117: 1468-1474.
56. PHADNIS SV, ATILADE A, BOWRING J, KYRGIOU M, YOUNG MP, EVANS H, PARASKEVAIDIS E, WALKER P. Regeneration of cervix after excisional treatment for cervical intraepithelial neoplasia: a study of collagen distribution. BJOG 2011; 118: 1585-1591.
57. KYRGIOU M, ARBYN M, MARTIN-HIRSCH P, PARASKEVAIDIS E. Increased risk of preterm birth after treatment for CIN. Br Med J 2012; 345: e5847.
58. RICCIOTTI HA, CALAYAG PT, ABBOTT J, LUDMIR J. Obstetric outcome after failed termination of pregnancy- a report of two cases. Am J Obstet Gynecol 1995; 173: 1619-1620.
59. CRUICKSHANK ME, FLANNELLY G, CAMPBELL DM, KITCHENER HC. Fertility and pregnancy outcome following large loop excision of the cervical transformation zone. Br J Obstet Gynaecol 1995; 102: 467-470.
60. FERENCZY A, CHOUKROUN D, FALCONE T, FRANCO. E The effect of cervical loop electrosurgical excision on subsequent pregnancy outcome: North American experience. Am J Obstet Gynecol 1995; 172: 1246-1250.
61. PARASKEVAIDIS E, KOLIOPOULOS G, LOLIS E, PAPANIKOU E, MALAMOU-MITSI V, AGNANTIS NJ. Delivery outcomes following loop electrosurgical excision procedure for microinvasive (FIGO stage IA1) cervical cancer. Gynecol Oncol 2002; 86: 10-13.
62. TSENG CJ, SOONG YK, LIANG CC, HSUEH S. Loop excision for cervical intraepithelial neoplasia. J Formos Med Assoc 1992; 91: 1059-1063.
63. KYRGIOU M, KOLIOPOULOS G, MARTIN-HIRSCH P, ARBYN M, PRENDIVILLE W, PARASKEVAIDIS E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006; 367: 489-498.
64. NOEHR B, JENSEN A, FREDERIKSEN K, TABOR A, KJAER SK. Depth of cervical cone removed by loop electrosurgical excision procedure and subsequent risk of spontaneous preterm delivery. Obstet Gynecol 2009; 114: 1232-1238.
65. SHANBHAG S, CLARK H, TIMMARAJU V, BHATTACHARYA S, CRUICKSHANK M. Pregnancy outcome after treatment for cervical intraepithelial neoplasia. Obstet Gynecol 2009; 114: 727-735.
66. AVERETTE HE, NASSER N, YANKOW SL, LITTLE WA. Cervical conization in pregnancy. Analysis of 180 operations. Am J Obstet Gynecol 1970; 106: 543-549.
67. HANNIGAN EV, WHITEHOUSE 3RD HH, ATKINSON WD, BECKER SN. Cone biopsy during pregnancy. Obstet Gynecol 1982; 60: 450-455.
68. VAN HENTENRYCK M, NOEL JC, SIMON P. Obstetric and neonatal outcome after surgical treatment of cervical dysplasia. Eur J Obstet Gynecol Reprod Biol 2012; 162: 16-20.
69. DISAIA PCW. Clinical Gynecoloical Oncology. St Louis (MO); Mosby Inc 2002.
70. ZUO Z, GOEL S. CARTER JE. Association of cervical cytology and HPV DNA status during pregnancy with placental abnormalities and preterm birth. Am J Clin Pathol 2011; 136: 260-265.
71. SKOCZY SKI M, GO DZICKA-JÓZEFIAK A, KWA NIEWSKA A. PREVALENCE of human papillomavirus in spontaneously aborted products of conception. Acta Obstet Gynecol Scand 2011; 90: 1402-1405.
72. KHALID S, DIMITRIOU E, CONROY R, PARASKEVAIDIS E, KYRGIOU M, HARRITY C, ARBYN M, PRENDIVILLE W. The thickness and volume of LLETZ specimens can predict the relative risk of pregnancy-related morbidity. BJOG 2012; 119: 685-691.
73. CASTANON A, BROCKLEHURST P, EVANS H, PEEBLES D, SINGH N, WALKER P, PATNICK J, SASIENI P, PACT STUDY GROUP. Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospectiveprospective cohort study. Br Med J 2012; 16; 345:e5174. doi: 10.1136/bmj.e5174.